A retrospective study of citalopram in adolescents with depression

Journal of Child and Adolescent Psychopharmacology

Volumn 11, Issue 2, 2001, Pages 159-166

  Bostic, J Q ^a,b,c   Prince, J ^a   Brown, K ^b,c   Place, S ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c CLM Behavioral Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE DERIVATIVE; CITALOPRAM; CLONIDINE; FLUVOXAMINE; GABAPENTIN; GUANFACINE; LITHIUM; LORAZEPAM; METHYLPHENIDATE; MIRTAZAPINE; PAROXETINE; PEMOLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; VALPROIC ACID; VENLAFAXINE;

ADOLESCENT; AGITATION; ARTICLE; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEALTH CENTER; HUMAN; MALE; NAUSEA; SCHOOL CHILD; SEDATION; VERTIGO;

EID: 0034949899     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454601750284063     Document Type: Article

References (35)

1. Antidepressant treatments in children and adolescents: I. Affective disorders
2. Multicenter open-label sertraline study in adolescent outpatients with major depression
3. SSRI safety in overdose
4. The pharmacokinetics of citalopram
5. Juvenile mood disorders and office psychopharmacology
6. Extended open-label fluoxetine treatment of adolescents with major depression
7. Fluvoxamine in the treatment of depressive illness in children and adolescents
8. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
9. Multicenter, placebo-controlled, fixed dose study of citalopram in moderate to severe depression
10. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children
11. Drug interactions with newer antidepressants: Role of human cytochromes P450
12. The pharmacokinetic profile of citalopram in adolescents and adults with major depressive disorder (MDD)
13. Efficacy of tricyclic drugs in treating child and adolescent depression: A meta-analysis
14. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder
15. Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse events
16. Paroxetine and imipramine in the treatment of adolescent depression
17. Presentation and course of major depressive disorder during childhood and later years of the life span
18. Citalopram in the treatment of social phobia: A report of three cases
19. Citalopram in the treatment of early-onset panic disorder and school phobia
20. Adolescent psychopathology, I: Prevalence and incidence of depression and other DSM-III-R disorders in high school students
21. Paroxetine in depressed adolescents with intellectual disability: An open label study
22. An open study of the effects of sertraline on adolescent major depression
23. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia
24. The optimal dosing regimen for citalopram - A meta-analysis of nine placebo-controlled studies
25. Clinical Global Impression (CGI)
26. Citalopram: A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
27. Paroxetine in children with major depressive disorder: An open trial
28. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors
29. Adolescent depression: A placebo-controlled fluoxetine treatment study and follow-up
30. Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases
31. Sertraline for major depression in children and adolescents: Preliminary clinical experience
32. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents
33. Case study: Nefazodone for juvenile mood disorders
34. Clinical development of citalopram